# K143087: Hospira Blood Set

- Pathway: 510(k) (Traditional)
- Applicant: Hospira, Inc.
- Decided: Mar 4, 2015 after 128 days
- Product code: FPA (Set, Administration, Intravascular)
- Device class: 2
- Regulation: 21 CFR 880.5440
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K030467 (2003). 5 ancestors in all.
2 later devices descend from it; 1 cites it directly.
1 of 8 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K101677: Hospira Infusion Blood Sets, Hospira, Inc. (2010) Summary page 5.

## Most influential descendants
- K160870: Hospira Administration Sets (2016), 1 descendant of its own
- K192375: Intellifuse Administration and Intellifuse Blood Administration Sets (2020), 0 descendants of its own

## Indications for use
Hospira Blood sets are indicated for the delivery of fluids including but not limited to blood and blood products from a container to a patient’s vascular system.

Source page: https://510kreport.com/device/K143087
Methodology: https://510kreport.com/methodology